News | Cath Lab | April 03, 2017

Study Examines Influence of Cardiac Arrest and Cardiogenic Shock on STEMI Patient Outcomes

Minneapolis Heart Institute Foundation study finds that presence of cardiac arrest and/or cardiogenic shock is responsible for more than 75 percent of hospital deaths in STEMI patients

STEMI, cardiac arrest, cardiogenic shock, ACC.17 study, Minneapolis Heart Institute Foundation, MHIF

April 3, 2017 — The influence of cardiac arrest and cardiogenic shock on outcomes of patients with ST-elevation myocardial infarction (STEMI) has not been completely studied. Researchers at the Minneapolis Heart Institute Foundation (MHIF) conducted a study to determine the incidence, characteristics and outcomes of STEMI complicated by cardiac arrest with or without cardiogenic shock.

Prospective data from the Level I regional STEMI program at the Minneapolis Heart Institute at Abbott Northwestern Hospital was examined from March 2003 to December 2014. Researchers analyzed STEMI patients who had cardiac arrest prior to any intervention. They specifically sought to determine how the type of cardiac arrest (shockable versus non-shockable rhythm) and the presence of cardiogenic shock affect patient outcomes.

MHIF researchers, led by Benjamin Johnson, M.D., enrolled 4,511 patients in this study. The incidence of cardiac arrest prior to intervention was 11 percent. In-hospital death occurred in 250 (6 percent) of patients. Cardiac arrest was present in 56 percent and cardiogenic shock in 53 percent of these patients. In patients with shockable cardiac arrest, in-hospital mortality was 2.8x higher if they had cardiogenic shock as compared to no cardiogenic shock. In patients with non-shockable cardiac arrest, in-hospital mortality was equally high regardless of the presence of cardiogenic shock. Among this 4,511-patient cohort, cardiac arrest and/or cardiogenic shock accounted for 76 percent of all hospital deaths. 

Johnson noted, “Cardiac arrest and cardiogenic shock are associated with significantly increased morbidity and mortality in patients presenting with ST elevation myocardial infarction. Efforts need to be made to better understand this population of patients presenting with STEMI complicated by cardiac arrest with or without cardiogenic shock.”

Results of the study were presented at the American College of Cardiology Annual Scientific Session & Expo (ACC.17), March 17-19 in Washington, D.C.

Read about another cariogenic shock study presented at ACC.17., “New Protocol at Henry Ford Hospital Dramatically Increases Heart Attack Survival Rates.”

Watch the VIDEO "VIDEO: Cardiogenic Shock Supported With Impella Shows Good Outcomes."

For more information: www.mplsheart.org

Related Content

Videos | ACC| April 03, 2017
DAIC Editor Dave Fornell takes a tour of some of the interesting new technologies from the vendor booths on the expo
ACC.17 late breaking trial presentations, ACC late-breakers,  American College of Cardiology late breaking studies
Feature | ACC| March 22, 2017
Here is a list of the American College of Cardiology (ACC) 2017 annual meeting late-breaking clinical trials presente
Siemens Sensis Vibe, hemodyanamics system

Siemens released the Sensis Vibe hemodyanamics system at ACC.16. The newer system offers better integration of cath lab data into cath lab reports and the electronic medical record (EMR).

Feature | ACC| April 25, 2016 | Jon Brubaker, MBA, RCVT, Tom Watson, BS, RCVT, and Sabrina Newell MS, RCS
There were several trends seen in new cardiovascular technologies showcased on the expo floor at the 2016 American...
Videos | ACC| April 25, 2016
MD Buyline market analyst Jon Brubaker explained the new technology and trends he saw on the show floor at ACC.16. 
Videos | ACC| April 25, 2016
Michael Jaff, M.D., medical director of Massachusetts General Hospital’s Fireman Vascular Center, explains the curren
Videos | ACC| April 15, 2016
DAIC Editor Dave Fornell takes a tour of some of the trends and interesting new technologies from the vendor booths o
Videos | ACC| April 15, 2016
MDbuyline clinical analyst Tom Watson, BS, RCVT, explains the new hemodynamic system technology trends at ACC.16.
ACC late breakers
News | ACC| February 09, 2016
The following are the late-breaking clinical trial presentations presented at the 2016 American College of Cardiology

Photo courtesy of Vital Images

News | ACC| December 22, 2015
December 22, 2015 — In 2015, results from the ITALIC and CvLPRIT trials, along with studies examining lifestyle facto
Videos | ACC| March 25, 2015
DAIC Editor Dave Fornell shares his picks of the most interesting new devices and advances in cardiovascular technolo
Overlay Init